NUNZ OTC
Nunzia Pharmaceutical Company
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.0001-0.0001
Volume10,000
Avg Volume3,111
Beta-2.87
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOSara Gonzales
Employees4
SectorHealthcare
IndustryMedical - Pharmaceuticals
IPO Date2009-07-24
Websitenunziapharma.com
1627 West 14th Street
Long Beach, CA 90813
US
Long Beach, CA 90813
US
714 609 9117
About Nunzia Pharmaceutical Company
Nunzia Pharmaceutical Company operates as a pharmaceutical and nutraceutical company. The company owns the right to manufacture, market, and distribute Nunzia, a nutraceutical that treats autism, fragile X, ADHD, PTSD, and other disorders. It offers its products through wholesalers, as well as through its website nunziapharma.com. The company was formerly known as Arizona Gold and Onyx Mining Company and changed its name to Nunzia Pharmaceutical Company in February 2018. Nunzia Pharmaceutical Company was incorporated in 1986 and is based in Long Beach, California.
Latest News
No recent news
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| HENRY G DAVID | P-Purchase | 25,000 | $0.02 | 2006-10-30 |
| HENRY G DAVID | P-Purchase | 100,000 | $0.02 | 2006-10-18 |
| HENRY G DAVID | P-Purchase | 10,000 | $0.02 | 2006-06-14 |
| HENRY G DAVID | P-Purchase | 3,913 | $0.04 | 2006-05-03 |
| HENRY G DAVID | P-Purchase | 55,000 | $0.42 | 2006-05-02 |